Actionability = is there something to do. Prevalence = how much of a general GI practice it touches. Stakes = how consequential the decision is. Evidence strength = how far the study design and the result support the action. Novelty = how likely you are not already doing it.
Nutritionprospective cohort · n=242,464 · Nov 13, 2026 · JPEN · IF 3.2
Clinical takeawayConsider using these cutoffs in older Japanese outpatients and hospitalized adults to assess severe muscle mass reduction and stratify mortality risk, particularly in those undergoing dual-energy X-ray absorptiometry or bioelectrical impedance analysis. Further validation in other populations is needed.
What it foundSevere muscle mass reduction cutoffs for appendicular skeletal muscle mass index were <6.4 kg/m2 in men and <5.0 kg/m2 in women, and for fat-free mass index were <16.0 kg/m2 in men and <13.4 kg/m2 in women, associated with 2.04-fold higher mortality (95% CI: 1.97-2.12).
ContextThis study establishes specific cutoffs for severe muscle mass reduction in older Japanese adults, refining the Global Leadership Initiative on Malnutrition criteria and providing prognostic risk stratification. The cutoffs were validated in a nationwide cohort of hospitalized adults, showing a 2.04-fold higher mortality risk (95% CI: 1.97-2.12).
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Takagi S … Arai H · JPEN. Journal of Parenteral and Enteral Nutrition · IF 3.2 · PubMed ↗Permalink
Nutritionprospective cohort · n=12 · Nov 15, 2026 · JPEN · IF 3.2
New evidenceenteral nutritionparenteral nutritionshort bowel syndromeartificial intelligence
Clinical takeawayNo clinical action yet: this is a small descriptive cohort study; prospective trials are needed to confirm safety and efficacy.
ContextThis literature reports that chyme reinfusion using an automated device is technically feasible and safe for hospitalized adults with high-output stomas or enterocutaneous fistulas.
No standard claimed for this paper
Every paper is compared to the standard governing its question. This one is not: either no standard in the corpus matches it, or the comparison did not hold up on review and was withdrawn rather than published unverified. Both are logged.
Boros M … Ris F · JPEN. Journal of Parenteral and Enteral Nutrition · IF 3.2 · PubMed ↗Permalink